Tag: Central retinal vein occlusion

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Central retinal vein occlusion

Global Retinal Vein Occlusion Market 2021 Future Growth Explored in Latest Research Report by ...

Added to Collection on: 2021-01-14 15:38:32

Tags for this article:

Organ systems
Anatomy
Medical specialties
Central retinal vein occlusion
Ocular ischemic syndrome
Central retinal vein
Retina
Branch retinal artery occlusion
Central retinal artery
Marketplace

Click the tags to see associated articles and topics

View Article Details
FDA grants approval for Eylea®1) biosimilar FYB203/AHZANTIVE®2) (aflibercept-mrbb)

Added to Collection on: 2024-06-29 10:00:22

Tags for this article:

Angiogenesis inhibitors
Aflibercept
Sanofi
Blindness
Macular edema
Diabetic retinopathy
Macular degeneration
Central retinal vein occlusion
Forward-looking statement
Regeneron Pharmaceuticals
Biosimilar
Macula
Formycon AG
Eylea

Click the tags to see associated articles and topics

View Article Details
FDA approves faricimab-svoa prefilled syringe - Modern Retina

Added to Collection on: 2024-07-05 22:31:46

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Macular edema
Macular degeneration
Vascular endothelial growth factor
Diabetic retinopathy
Genentech
Central retinal vein occlusion
Faricimab
Ranibizumab
Roche Group
Adobe
United States

Click the tags to see associated articles and topics

View Article Details
Roche's eye drug Vabysmo receives EU approval for a further indication - MarketScreener

Added to Collection on: 2024-07-30 17:39:49

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Macular edema
Faricimab
Aflibercept
Central retinal vein occlusion
Diabetic retinopathy
Ranibizumab
Central retinal vein
Macular degeneration
Retina

Click the tags to see associated articles and topics

View Article Details
FDA approves Roche's Susvimo as the first and only - GlobeNewswire

Added to Collection on: 2025-02-04 16:59:57

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Macular edema
Ranibizumab
Eye diseases
Intravitreal administration
Diabetic retinopathy
Faricimab
Macular degeneration
Intravitreal injection
Central retinal vein occlusion
Retina
Roche Group
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded For Macular Edema Secondary to ...

Added to Collection on: 2025-08-15 19:02:23

Tags for this article:

Angiogenesis inhibitors
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Diabetic retinopathy
Aflibercept
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
Retinopathy
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? - TradingView

Added to Collection on: 2025-09-15 15:32:00

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Cemiplimab
Central retinal vein occlusion
Priority review
Eylea
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
VABYSMO® (faricimab injection) Now Publicly Funded for Macular Edema Secondary to ...

Added to Collection on: 2025-09-29 14:46:28

Tags for this article:

Angiogenesis inhibitors
Retinopathy
Monoclonal antibodies
Blindness
Faricimab
Macular edema
Aflibercept
Diabetic retinopathy
Central retinal vein occlusion
Branch retinal vein occlusion
Macular degeneration
Retina
HOFFMANN-LA ROCHE LIMITED
Roche Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Book a Demo